NCT04800146View on ClinicalTrials.gov

A Study on the Immune-response to COVID-19 Vaccination in Cancer Patients - the IOSI-COVID-19-001 Study

CompletedOBSERVATIONAL

Enrollment

177

Participants

Timeline

Start Date

February 25, 2021

Primary Completion Date

March 21, 2023

Study Completion Date

March 21, 2023

Conditions

Covid19Cancer

Interventions

PROCEDURE

Blood sample

Patients will be asked to provide blood samples at specified time points: before and after the SARS-CoV-2 vaccination

Trial Locations (1)

6500

Oncology Institute of Southern Switzerland, Bellinzona

All Listed Sponsors

collaborator

Institute for Research in Biomedicine

UNKNOWN

collaborator

Ente Ospedaliero Cantonale, Bellinzona

OTHER

lead

Ilaria Colombo

OTHER

NCT04800146 - A Study on the Immune-response to COVID-19 Vaccination in Cancer Patients - the IOSI-COVID-19-001 Study | Biotech Hunter | Biotech Hunter